Accolade (STU:4NE1) Change In Payables And Accrued Expense : €6.4 Mil (TTM As of Nov. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Accolade Change In Payables And Accrued Expense?

Accolade's Change In Payables And Accrued Expense for the quarter that ended in Nov. 2024 was €6.1 Mil. It means Accolade's Accounts Payable & Accrued Expense increased by €6.1 Mil from Aug. 2024 to Nov. 2024 .

Accolade's Change In Payables And Accrued Expense for the fiscal year that ended in Feb. 2024 was €-11.7 Mil. It means Accolade's Accounts Payable & Accrued Expense declined by €11.7 Mil from Feb. 2023 to Feb. 2024 .

Accolade Change In Payables And Accrued Expense Historical Data

The historical data trend for Accolade's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accolade Change In Payables And Accrued Expense Chart

Accolade Annual Data

Trend

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

3.82

16.00

-3.89

1.20

-11.66

Accolade Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															1.87	0.92	-6.20	5.59	6.08

Accolade Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.4 Mil.

Accolade Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Accolade's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Accolade Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accolade Inc (STU:4NE1) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1201 Third Avenue, Suite 1700, Seattle, WA, USA, 98101

Website

https://www.accolade.com

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Accolade Headlines

No Headlines